NO20052798L - (-) Enantiomer av Tenatoprazol og dens Terapeutiske anvendelse - Google Patents

(-) Enantiomer av Tenatoprazol og dens Terapeutiske anvendelse

Info

Publication number
NO20052798L
NO20052798L NO20052798A NO20052798A NO20052798L NO 20052798 L NO20052798 L NO 20052798L NO 20052798 A NO20052798 A NO 20052798A NO 20052798 A NO20052798 A NO 20052798A NO 20052798 L NO20052798 L NO 20052798L
Authority
NO
Norway
Prior art keywords
tenatoprazole
enantiomers
therapeutic use
enantiomer
methoxy
Prior art date
Application number
NO20052798A
Other languages
English (en)
Other versions
NO331505B1 (no
Inventor
Avraham Cohen
Herve Ficheux
Michel Homerin
Francois Schutze
Suzy Charbit
Alain Taccoen
Original Assignee
Sidem Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sidem Pharma Sa filed Critical Sidem Pharma Sa
Publication of NO20052798L publication Critical patent/NO20052798L/no
Publication of NO331505B1 publication Critical patent/NO331505B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Foreliggende oppfinnelse angår enantiomeren av tenatoprazol. Den innovative enantiomeren av tenatoprazol, eller 5-metoksy-2-[[(4-metoksy-3,5-dimetyl-2pyridyl)metyllsulfmyllimidazo[4,5-b]pyridin oppviser forbedrede farmakokinetiske egenskaper hvilket gjør det mulig å anvende en enkelt daglig dose av et medikament for relevante indikasjoner. Oppfinnelsen kan anvendes ved behandling av fordøyelsessykdommer.
NO20052798A 2002-12-16 2005-06-09 (-) Enantiomeren av tenatoprazol, farmasoytisk preparat inneholdende denne samt anvendelse av denne for fremstilling av medisinsk preparat for behandling av sykdom NO331505B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0215949A FR2848555B1 (fr) 2002-12-16 2002-12-16 Enantiomere(-)du tenatoprazole et son application en therapeutique
PCT/FR2003/003746 WO2004060891A1 (fr) 2002-12-16 2003-12-16 Enantiomere (-) du tenatoprazole et son application en therapeutique

Publications (2)

Publication Number Publication Date
NO20052798L true NO20052798L (no) 2005-07-04
NO331505B1 NO331505B1 (no) 2012-01-16

Family

ID=32338855

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052798A NO331505B1 (no) 2002-12-16 2005-06-09 (-) Enantiomeren av tenatoprazol, farmasoytisk preparat inneholdende denne samt anvendelse av denne for fremstilling av medisinsk preparat for behandling av sykdom

Country Status (16)

Country Link
US (2) US7034038B2 (no)
EP (1) EP1572692A1 (no)
JP (1) JP5230897B2 (no)
KR (3) KR20140022437A (no)
CN (1) CN100345849C (no)
AU (1) AU2003300627B2 (no)
BR (1) BR0317328A (no)
CA (1) CA2509899C (no)
FR (1) FR2848555B1 (no)
IL (1) IL168782A (no)
MX (1) MXPA05006419A (no)
NO (1) NO331505B1 (no)
NZ (1) NZ540663A (no)
PL (1) PL215162B1 (no)
RU (1) RU2310652C2 (no)
WO (1) WO2004060891A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
US7507746B2 (en) * 2003-02-24 2009-03-24 Mitsubishi Pharma Corporation Enantiomer of tenatoprazole and the use thereof in therapy
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
FR2876101B1 (fr) * 2004-10-05 2007-03-02 Sidem Pharma Sa Sa Procede de preparation enantioselective de derives de sulfoxydes
WO2006043280A1 (en) * 2004-10-19 2006-04-27 Council Of Scientific And Industrial Research Tenatoprazole salts and process of preparation thereof
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
CN101497623B (zh) * 2008-01-30 2011-01-12 山东轩竹医药科技有限公司 含有咪唑并吡啶的化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8204879D0 (sv) 1982-08-26 1982-08-26 Haessle Ab Novel chemical intermediates
JPH0643426B2 (ja) 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
MXPA05005762A (es) * 2002-12-06 2005-08-16 Altana Pharma Ag Procedimiento para preparar compuestos activos opticamente puros.
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique

Also Published As

Publication number Publication date
FR2848555A1 (fr) 2004-06-18
BR0317328A (pt) 2005-11-08
CA2509899C (fr) 2012-07-03
PL215162B1 (pl) 2013-10-31
JP2006513230A (ja) 2006-04-20
US7034038B2 (en) 2006-04-25
AU2003300627A1 (en) 2004-07-29
AU2003300627B2 (en) 2009-07-23
JP5230897B2 (ja) 2013-07-10
KR20120087886A (ko) 2012-08-07
NO331505B1 (no) 2012-01-16
KR20050088184A (ko) 2005-09-02
EP1572692A1 (fr) 2005-09-14
CA2509899A1 (fr) 2004-07-22
IL168782A (en) 2013-05-30
KR20140022437A (ko) 2014-02-24
US20050119298A1 (en) 2005-06-02
PL377738A1 (pl) 2006-02-20
WO2004060891A1 (fr) 2004-07-22
US7652034B2 (en) 2010-01-26
NZ540663A (en) 2007-12-21
RU2310652C2 (ru) 2007-11-20
CN100345849C (zh) 2007-10-31
MXPA05006419A (es) 2006-03-08
CN1726214A (zh) 2006-01-25
US20060194832A1 (en) 2006-08-31
FR2848555B1 (fr) 2006-07-28
RU2005122465A (ru) 2006-01-20

Similar Documents

Publication Publication Date Title
NO20052798L (no) (-) Enantiomer av Tenatoprazol og dens Terapeutiske anvendelse
WO1998054171A8 (en) Novel form of s-omeprazole
NO20064000L (no) Heteroarylkoblede pyrazoloderivater
PT1202736E (pt) Nicotina na angiogénese e vasculogénese terapêuticas
WO2002017358A3 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
NO20035036L (no) Tartratsalter av 5,8,14-triazatetracyklo (10.3.1.02,11.04.9)- heksadeka-2 (11),3,5,7,9-pentaen og farmasöytiske sammensetningerderav
MY127871A (en) Omeprazole sodium salt
AP2005003424A0 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders; process for their preparation and pharmaceutical compositions containing them.
HK1075450A1 (en) heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine
HUP0104379A2 (hu) Omeprazol új kristályos formája és ezt tartalmazó gyógyszerkészítmény
HUP0401086A3 (en) 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for preparation of pharmaceutical compositions for the treatment of pain, anxiety or gastrointestinal disorders and process for preparation the compounds
WO2002085857A3 (en) Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
YU31494A (sh) Omeprazol enantiomeri, postupak za njihovo dobijanje, farmaceutski proizvodi i njihova upotreba u medicini
IL163102A (en) Dihydrobenzodiazepin-2-one derivatives, process for their preparation and use thereof in the preparation of medicaments for the treatment of neurological disorders
IL188942A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
HUP9900386A2 (hu) Fenoxi-piridin-származékok alkalmazása szívelégtelenség kezelésére alkalmas gyógyszerkészítmények előállítására
HUP0303928A2 (hu) Omeprazol kristályos formája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
DE60108626D1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer
MY118199A (en) Process for preparing omeprazole
NO20020031L (no) Dihydrobenzodiazepiner og deres anvendelse til behandling av dyslipidemi
NO20062570L (no) Imidazo[1,2-A] pyridin derivater for behandling av stille gastroosofagial refluks
SE0302382D0 (sv) New salts II
DE60324696D1 (de) Bizyklische heteroaromatische verbindungen als kinase hemmstoffe
ATE355290T1 (de) (5-(PYRIDIN-3-YL)-1-AZABICYCLO(3.2.1) OCTAN DERIVATE, DEREN HERSTELLUNG UND DEREN VERWENDUNG IN THERAPEUTIKAß
MXPA06000193A (es) Derivados de imidazol iii.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees